A prospective, multi-center, single-group target value method to evaluate the safety and effectiveness of the Aorta Arch Stent Graft System combined with the Endovascular Needle System in situ fenestration technology in the treatment of aortic dissection involving the aortic arch
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Primary safety end point of the Aorta Arch Stent Graft System: no Major Adverse events(MAE) occurrence within 30 days after surgery
Timeframe: Within 30 days after procedure
Primary efficacy endpoint of the Aorta Arch Stent Graft System: treatment success at 12 months after surgery
Timeframe: 12 months after procedure
Primary endpoint of the Endovascular Needle System: Immediate surgical success rate of the Endovascular Needle System
Timeframe: intraoperative